APA (7th ed.) Citation

Jensen, A., Krauß, J., Potthoff, K., Desta, A., Habl, G., Mavtratzas, A., . . . Münter, M. (2011). Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT. BMC cancer, 11, . https://doi.org/10.1186/1471-2407-11-182

Chicago Style (17th ed.) Citation

Jensen, Alexandra, Jürgen Krauß, Karin Potthoff, Almaz Desta, Gregor Habl, Athanasios Mavtratzas, Christine Windemuth-Kiesselbach, Jürgen Debus, and Marc Münter. "Phase II Study of Induction Chemotherapy with TPF Followed by Radioimmunotherapy with Cetuximab and Intensity-modulated Radiotherapy (IMRT) in Combination with a Carbon Ion Boost for Locally Advanced Tumours of the Oro-, Hypopharynx and Larynx - TPF-C-HIT." BMC Cancer 11 (2011). https://doi.org/10.1186/1471-2407-11-182.

MLA (9th ed.) Citation

Jensen, Alexandra, et al. "Phase II Study of Induction Chemotherapy with TPF Followed by Radioimmunotherapy with Cetuximab and Intensity-modulated Radiotherapy (IMRT) in Combination with a Carbon Ion Boost for Locally Advanced Tumours of the Oro-, Hypopharynx and Larynx - TPF-C-HIT." BMC Cancer, vol. 11, 2011, https://doi.org/10.1186/1471-2407-11-182.